{"altmetric_id":18428934,"counts":{"readers":{"mendeley":8,"citeulike":0,"connotea":0},"total":{"posts_count":6},"twitter":{"unique_users_count":6,"unique_users":["CancerPapers","gedefo_sefh","CGuindel","MariaFdzPacheco","jtitos2","FarmaOnco"],"posts_count":6}},"selected_quotes":["SAFE trial: cardiotoxicity prevention in breast cancer patients treated with anthracyclines +- trastuzumab","SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in\u2026 #breastcancer"],"citation":{"abstract":"Over the years, thanks to the addition of new generation systemic agents, as well as the use of more advanced and precise radiotherapy techniques, it was able to obtain a high curability rate for breast cancer. Anthracyclines play a key role in the treatment of breast disease, with a well-known benefit on disease-free survival of patients with positive nodal status. Trastuzumab have shown a significant outcome advantage after 1-year administration in case of HER2-positive disease. Unfortunately, significant increase in cardiotoxicity has been observed after anthracyclines and trastuzumab therapies. Even though the cardiology and oncology community strongly recommend a cardiotoxicity prevention strategy for this subset of patients, there is still no consensus on the optimal patient's approach. We aimed to review the published and ongoing researches on cardioprevention strategies and to present the SAFE trial (CT registry ID: NCT2236806; EudraCT number: 2015-000914-23). It is a randomized phase 3, four-arm, single-blind, placebo-controlled study that aims to evaluate the effect of bisoprolol, ramipril or both drugs, compared to placebo, on subclinical heart damage evaluated by speckle tracking cardiac ultrasound in non-metastatic breast cancer patients.","altmetric_jid":"4f6fa62c3cf058f61000812e","authors":["Meattini, Icro","Curigliano, Giuseppe","Terziani, Francesca","Becherini, Carlotta","Airoldi, Mario","Allegrini, Giacomo","Amoroso, Domenico","Barni, Sandro","Bengala, Carmelo","Guarneri, Valentina","Marchetti, Paolo","Martella, Francesca","Piovano, Pierluigi","Vannini, Agnese","Desideri, Isacco","Tarquini, Roberto","Galanti, Giorgio","Barletta, Giuseppe","Livi, Lorenzo","Icro Meattini","Giuseppe Curigliano","Francesca Terziani","Carlotta Becherini","Mario Airoldi","Giacomo Allegrini","Domenico Amoroso","Sandro Barni","Carmelo Bengala","Valentina Guarneri","Paolo Marchetti","Francesca Martella","Pierluigi Piovano","Agnese Vannini","Isacco Desideri","Roberto Tarquini","Giorgio Galanti","Giuseppe Barletta","Lorenzo Livi"],"doi":"10.1007\/s12032-017-0938-x","first_seen_on":"2017-04-02T10:23:49+00:00","funders":["niehs"],"issns":["1357-0560","1559-131X"],"issue":"5","journal":"Medical Oncology","last_mentioned_on":1493094690,"links":["https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28364270?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter","http:\/\/link.springer.com\/article\/10.1007%2Fs12032-017-0938-x"],"pdf_url":"https:\/\/link.springer.com\/content\/pdf\/10.1007%2Fs12032-017-0938-x.pdf","pmid":"28364270","pubdate":"2017-05-01T00:00:00+00:00","publisher":"Springer Nature","publisher_subjects":[{"name":"Hematology","scheme":"springer"},{"name":"Internal Medicine","scheme":"springer"},{"name":"Medicine & Public Health","scheme":"springer"},{"name":"Oncology","scheme":"springer"},{"name":"Pathology","scheme":"springer"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms"],"title":"SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab","type":"article","volume":"34","mendeley_url":"http:\/\/www.mendeley.com\/research\/safe-trial-ongoing-randomized-clinical-study-assess-role-cardiotoxicity-prevention-breast-cancer-pat"},"altmetric_score":{"score":2.95,"score_history":{"1y":2.95,"6m":2.95,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":2.95},"context_for_score":{"all":{"total_number_of_other_articles":8098931,"mean":6.8880547472244,"rank":3148362,"this_scored_higher_than_pct":60,"this_scored_higher_than":4939220,"rank_type":"exact","sample_size":8098931,"percentile":60},"similar_age_3m":{"total_number_of_other_articles":237724,"mean":13.109248242702,"rank":84453,"this_scored_higher_than_pct":64,"this_scored_higher_than":152529,"rank_type":"exact","sample_size":237724,"percentile":64},"this_journal":{"total_number_of_other_articles":576,"mean":1.7443860869565,"rank":135,"this_scored_higher_than_pct":76,"this_scored_higher_than":441,"rank_type":"exact","sample_size":576,"percentile":76},"similar_age_this_journal_3m":{"total_number_of_other_articles":30,"mean":5.5741379310345,"rank":6,"this_scored_higher_than_pct":80,"this_scored_higher_than":24,"rank_type":"exact","sample_size":30,"percentile":80}}},"demographics":{"poster_types":{"member_of_the_public":6},"users":{"twitter":{"cohorts":{"Members of the public":6}},"mendeley":{"by_status":{"Student  > Ph. D. Student":3,"Other":1,"Student  > Bachelor":1,"Lecturer":3},"by_discipline":{"Medicine and Dentistry":6,"Biochemistry, Genetics and Molecular Biology":1,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"twitter":{"ES":2}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/CancerPapers\/statuses\/848481025688649729","license":"gnip","citation_ids":[18428934],"posted_on":"2017-04-02T10:23:35+00:00","author":{"name":"Cancer Papers","image":"https:\/\/pbs.twimg.com\/profile_images\/610454165983244288\/dcwghekI_normal.jpg","description":"Stay abreast of the latest developments in the fight against cancer with daily publications curated from PubMed.","id_on_source":"CancerPapers","tweeter_id":"3326766226","geo":{"lt":null,"ln":null},"followers":714},"tweet_id":"848481025688649729"},{"url":"http:\/\/twitter.com\/gedefo_sefh\/statuses\/855851923706085376","license":"gnip","citation_ids":[18428934],"posted_on":"2017-04-22T18:32:54+00:00","author":{"name":"GEDEFO","url":"http:\/\/www.sefh.es","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000753799388\/8561701cfcfbc3a7efa7ec153101b2ab_normal.jpeg","description":"Grupo de Farmacia Oncol\u00f3gica de la SEFH","id_on_source":"gedefo_sefh","tweeter_id":"2184775389","geo":{"lt":39.5,"ln":-3,"country":"ES"},"followers":1989},"tweet_id":"855851923706085376"},{"url":"http:\/\/twitter.com\/CGuindel\/statuses\/855870241452290048","license":"gnip","rt":["gedefo_sefh"],"citation_ids":[18428934],"posted_on":"2017-04-22T19:45:41+00:00","author":{"name":"Conchi Guindel","image":"https:\/\/pbs.twimg.com\/profile_images\/616991246305894401\/q2boVw2j_normal.jpg","id_on_source":"CGuindel","tweeter_id":"341720785","geo":{"lt":null,"ln":null},"followers":140},"tweet_id":"855870241452290048"},{"url":"http:\/\/twitter.com\/MariaFdzPacheco\/statuses\/855888465682198530","license":"gnip","rt":["gedefo_sefh"],"citation_ids":[18428934],"posted_on":"2017-04-22T20:58:06+00:00","author":{"name":"Maria Fdez Pacheco","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000771479017\/b6deecbd688293073dc8f4ee6f320c9d_normal.jpeg","description":"Farmaceutica del @Farmacia_HUPA. Centrada en mejorar la atenci\u00f3n al paciente #FarmaciaHospitalaria","id_on_source":"MariaFdzPacheco","tweeter_id":"1943698579","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":228},"tweet_id":"855888465682198530"},{"url":"http:\/\/twitter.com\/jtitos2\/statuses\/855892803922132993","license":"gnip","rt":["gedefo_sefh"],"citation_ids":[18428934],"posted_on":"2017-04-22T21:15:20+00:00","author":{"name":"Jose Carlos Titos","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","id_on_source":"jtitos2","tweeter_id":"2180793659","geo":{"lt":null,"ln":null},"followers":7},"tweet_id":"855892803922132993"},{"url":"http:\/\/twitter.com\/FarmaOnco\/statuses\/856727343964073984","license":"gnip","rt":["gedefo_sefh"],"citation_ids":[18428934],"posted_on":"2017-04-25T04:31:30+00:00","author":{"name":"FarmaOnco","image":"https:\/\/pbs.twimg.com\/profile_images\/2930931336\/c5ed1efcf9ddf36d4803c1ab88604f4f_normal.jpeg","description":"Farmac\u00e9utica hospitalaria que intenta mantenerse al d\u00eda en onco, hemato y otras cosas","id_on_source":"FarmaOnco","tweeter_id":"917639060","geo":{"lt":null,"ln":null},"followers":1673},"tweet_id":"856727343964073984"}]}}